Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels [0.03%]
德国脂蛋白Apheresis注册中心(DLAR)对降低升高的Lp(a)水平治疗选择的影响
Volker J J Schettler,Class L Neumann,Christian Peter et al.
Volker J J Schettler et al.
Background: The German Lipoprotein Apheresis Registry (DLAR) has been initiated by members of the Nephrology Foundation (WiNe), the German association of kidney centres (DN), the German society of nephrology (DGfN) and ad...
Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study [0.03%]
脂蛋白pheresis可稳定斑块并预防心血管事件发生——对Pro(a)LiFe研究的评论
Reinhard Klingel,Andreas Heibges,Cordula Fassbender
Reinhard Klingel
Elevated lipoprotein(a) (Lp(a)) has emerged as an important independent cardiovascular risk factor, and causal association has been accepted with adverse outcome in atherosclerotic disease. Lipoprotein apheresis (LA) can lower low-density l...
Peter Grützmacher,Claudius Kleinert
Peter Grützmacher
For long-term lipid apheresis therapy, several different technical systems have been developed which enable effective reduction of LDL cholesterol and other atherogenic lipoproteins, such as Lp(a), with sufficient selectivity and good clini...
Peter Schuff-Werner,Sebastian Fenger,Peter Kohlschein
Peter Schuff-Werner
During the last decades, LDL-apheresis was established as an extracorporeal treatment option for patients with severe heterozygous or homozygous familial hypercholesterolemia (FH) that is resistant to conventional treatment strategies such ...
Lipid apheresis - last resort or selective therapeutic option? Proceedings of a symposium held in Bad Oeynhausen, Germany, October 7 - 8, 2011. Editorial [0.03%]
脂蛋白吸附术-最后的手段还是选择性的治疗选项？2011年10月在Bad Oeynhausen，德国召开的一个讨论会论文集：编辑评论
Prof Dr Med D Horstkotte
Prof Dr Med D Horstkotte
[Three-dimensional reconstruction and remote navigation for catheter-guided atrial fibrillation ablation. Does it influence procedural outcomes?] [0.03%]
三维重建和导管消融房颤远程导航对其操作结果的影响？
Daniel Steven,Boris Hoffmann,Thomas Rostock et al.
Daniel Steven et al.
Catheter ablation of atrial fibrillation has evolved as a widely accepted therapy approach and is now also incorporated in the current guidelines.A major limitation consists of the limited three-dimensional visualization of the complex thre...
[Catheter ablation of atrial fibrillation. Pulmonary vein isolation by using a new multipolar ablation catheter] [0.03%]
[射频消融治疗房颤的新技术-多极导管肺静脉隔离]
Stefan G Spitzer,Laszlo Karolyi
Stefan G Spitzer
Catheter ablation of atrial fibrillation (AF) is an established therapeutical option, particularly in treatment of paroxysmal atrial fibrillation. This paper presents the results of using the PVAC multi-electrode ablation catheter (PVAC®, ...
Hans Volkmann,M Walter,C Walter et al.
Hans Volkmann et al.
Morbidity and mortality associated with atrial fibrillation are mainly related to thromboembolic complications, particularly ischemic strokes. The prevention of thromboembolism is an important component of the management of patients with at...
[Transapical aortic valve implantation--indications, risks and limitations] [0.03%]
经主动脉瓣膜植入术的指征、风险和限制因素
U Kappert,Dominik Joskowiak,S M Tugtekin et al.
U Kappert et al.
Calcified aortic stenosis is the predominant valve disease in the western world. Currently, surgical aortic valve replacement is the gold standard procedure for symptomatic severe aortic stenosis that can be performed with low morbidity and...
[3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective] [0.03%]
SYNTAX研究3年结果——从外科医生的视角看支架还是手术？
Lenard Conradi,Hermann Reichenspurner
Lenard Conradi
Coronary artery bypass grafting (CABG) is the standard of care for patients with three-vessel or left main coronary artery disease. However, clinical practice has proven to differ substantially with even the most complex coronary lesions be...